Welcome to our dedicated page for UNILEVER PLC SEC filings (Ticker: UL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on UNILEVER PLC's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into UNILEVER PLC's regulatory disclosures and financial reporting.
Unilever PLC updated its voting rights and capital. As at 31 October 2025, issued share capital consisted of 2,524,997,338 ordinary shares of 3 1/9p each. Of these, 71,366,436 were held as treasury shares and 1,743,681 were held by or on behalf of companies in the Unilever group; voting rights attaching to these group-held shares are not exercisable.
Accordingly, there were 2,451,887,221 shares with voting rights as at 31 October 2025. Shareholders may use 2,451,887,221 as the denominator when assessing whether they must notify their interest or changes under the UK Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.
Unilever PLC reported the availability of final terms for two euro-denominated senior notes issued by Unilever Capital Corporation under its $25,000,000,000 Debt Issuance Programme. The series comprise EUR 850,000,000 2.875% Notes due 31 October 2032 and EUR 800,000,000 3.500% Notes due 31 October 2037.
Both series are guaranteed by Unilever PLC and Unilever United States, Inc. The final terms must be read with the Information Memorandum dated 16 May 2025, as supplemented on 31 July 2025 and 24 October 2025. The documents are available via Unilever’s website and will be submitted to the UK National Storage Mechanism. This announcement is not an offer to sell or a solicitation to buy the securities.
Unilever PLC reported the outcome of its 30 April 2025 AGM vote on pay, noting that 72.29% supported the Directors' Remuneration Report. After the meeting, the company engaged with major shareholders representing 46.3% of the register and other dissenting investors and proxy agencies, holding 22 meetings to understand concerns.
Feedback focused on two areas: the past decision to disapply time pro‑ration on three long‑term incentive awards for former leaders Alan Jope and Graeme Pitkethly, and the approach to setting fixed pay for CEO Fernando Fernandez. Unilever described the non‑pro‑ration as an exceptional, legacy decision and confirmed it will apply time pro‑ration for future director exits, as shown when former CEO Hein Schumacher left in March 2025. On new appointments, the Board reflected preferences for phased pay: new CFO Srinivas Phatak (September 2025) was set below the prior CFO’s salary, with gradual movement over 2–3 years subject to performance and context.
The statement is issued under the UK Corporate Governance Code, with a final summary to appear in the next Annual Report and Accounts.
Unilever PLC filed a Form 6-K disclosing a management share transaction. Heiko Schipper, Business Group President, Foods, sold 4,173.37167 Unilever PLC ordinary shares at €53.484939 per share on 2025-10-27 on the Amsterdam Stock Exchange (XAMS), for an aggregate value of €223,212.53.
Unilever PLC filed a Form 6-K disclosing transactions by PDMR Fabian Garcia, Business Group President, Personal Care. On 2025/10/23, Garcia was granted 26,576.808 PLC ADR shares at $62.32, for an aggregate of $1,656,266.67, relating to TSA Award shares. On the same date, 24,461.862 PLC ADR shares tied to TSA Award shares were canceled. Both transactions were conducted outside a trading venue.
Unilever PLC reported that the UK Financial Conduct Authority approved a Supplement dated 24 October 2025 to the U.S.$25,000,000,000 Debt Issuance Programme of Unilever Finance Netherlands B.V., Unilever Capital Corporation and Unilever PLC (as issuers), with Unilever PLC and Unilever United States, Inc. as guarantors.
The Supplement is to be read with the Information Memorandum dated 16 May 2025, as previously supplemented on 31 July 2025. Links are provided to the Supplement and Unilever’s Q3 2025 full announcement, and the materials will be available via the UK National Storage Mechanism. This notice updates programme documentation and does not announce a specific securities issuance.
Unilever PLC submitted a Form 6-K as a foreign private issuer. The report is being formally incorporated by reference into existing shelf and employee share plan registration statements on Form F-3 and Form S-8. The filing mainly transmits an exhibit titled “Update on Demerger and Share Consolidation Timetable,” dated 21 October 2025, which is intended to inform investors about timing aspects of Unilever’s planned demerger and related share consolidation.
Unilever PLC has announced the appointment of Belén Garijo López as an independent Non-Executive Director, effective 13 May 2026. Ms. Garijo currently serves as Chair of the Executive Board and CEO of Merck Group until the end of April 2026, sits on the board of BBVA, and was a Non-Executive Director at L'Oreal from 2014 to 2024. The company highlights her global commercial experience across FMCG and healthcare and her record on diversity and transformation. The announcement complies with UK Listing Rule disclosures and provides no additional material details.